Literature DB >> 35747855

MEALTIME BOLUS INSULIN DOSE TIMING IN CHILDREN WITH TYPE 1 DIABETES: REAL-LIFE DATA FROM A TERTIARY CARE CENTRE IN NORTHERN INDIA.

L Rohilla1, D Dayal1, N Gujjar1, P Walia1, R Kumar1, J Yadav1.   

Abstract

Context: Mealtime insulin bolus is traditionally administered before meals in children with type 1 diabetes (T1D). Controlled studies on the use of pre-and postprandial insulin bolus have shown variable results. There are no real-world studies on postprandial bolusing of insulin in young children with T1D.
Methods: Children with T1D aged <7 years were grouped into preprandial (Group 1) or postprandial (Group 2) groups according to the practice of prandial insulin use. Their retrospective data on mean glycosylated hemoglobin (HbA1c), hypoglycemic events, and diabetic ketoacidosis (DKA) episodes were compared.
Results: Forty-four children (mean age 4.1±1.3 years, range 2-7 years) with mean diabetes duration of 2.0±0.7 years (range, 1-4 years) were identified; 23 (52.3%) belonged to Group 1 and 21 (47.7%) to Group 2. There were no differences in the mean HbA1c levels, mean hypoglycemic events, and DKA episodes between the two groups during a mean follow-up duration of two years.
Conclusion: Young children with T1D administered insulin bolus during or immediately after meals showed similar long-term glycemic control and diabetes-related adverse event profile compared to the premeal timing of insulin bolus. Larger real-world studies are needed on flexible insulin bolus timing in young children with T1D. ©2021 Acta Endocrinologica (Buc).

Entities:  

Keywords:  Type 1 diabetes; mealtime insulin bolus; rapid-acting insulins; young children

Year:  2021        PMID: 35747855      PMCID: PMC9206162          DOI: 10.4183/aeb.2021.528

Source DB:  PubMed          Journal:  Acta Endocrinol (Buchar)        ISSN: 1841-0987            Impact factor:   1.104


  14 in total

1.  Parent report of mealtime behavior and parenting stress in young children with type 1 diabetes and in healthy control subjects.

Authors:  Scott W Powers; Kelly C Byars; Monica J Mitchell; Susana R Patton; Debbie A Standiford; Lawrence M Dolan
Journal:  Diabetes Care       Date:  2002-02       Impact factor: 19.112

2.  Advantage of premeal-injected insulin glulisine compared with regular human insulin in subjects with type 1 diabetes.

Authors:  Klaus Rave; Oliver Klein; Annke D Frick; Reinhard H A Becker
Journal:  Diabetes Care       Date:  2006-08       Impact factor: 19.112

3.  ISPAD Clinical Practice Consensus Guidelines 2018: Insulin treatment in children and adolescents with diabetes.

Authors:  Thomas Danne; Moshe Phillip; Bruce A Buckingham; Przemyslawa Jarosz-Chobot; Banshi Saboo; Tatsuhiko Urakami; Tadej Battelino; Ragnar Hanas; Ethel Codner
Journal:  Pediatr Diabetes       Date:  2018-10       Impact factor: 4.866

4.  ISPAD Clinical Practice Consensus Guidelines 2018: Microvascular and macrovascular complications in children and adolescents.

Authors:  Kim C Donaghue; M Loredana Marcovecchio; R P Wadwa; Emily Y Chew; Tien Y Wong; Luis Eduardo Calliari; Bedowra Zabeen; Mona A Salem; Maria E Craig
Journal:  Pediatr Diabetes       Date:  2018-10       Impact factor: 4.866

5.  Efficacy comparison between preprandial and postprandial insulin aspart administration with dose adjustment for unpredictable meal size.

Authors:  Lois Jovanovic; Joyce Giammattei; Marilyn Acquistapace; Krista Bornstein; Erica Sommermann; David J Pettitt
Journal:  Clin Ther       Date:  2004-09       Impact factor: 3.393

6.  EFFICACY AND SAFETY OF BASAL INSULIN THERAPY IN ROMANIAN PATIENTS WITH TYPE 2 DIABETES IN REAL-LIFE SETTINGS: A SUB-GROUP ANALYSIS OF DUNE STUDY.

Authors:  A Cerghizan; P Amorin; D Catrinoiu; G Creteanu; E Adamescu; M Moise
Journal:  Acta Endocrinol (Buchar)       Date:  2020 Jan-Mar       Impact factor: 0.877

Review 7.  Flexibility of rapid-acting insulin analogues in children and adolescents with diabetes mellitus.

Authors:  Thomas Danne
Journal:  Clin Ther       Date:  2007       Impact factor: 3.393

8.  Comparison between preprandial vs. postprandial insulin aspart in patients with type 1 diabetes on insulin pump and real-time continuous glucose monitoring.

Authors:  Philippe Thuillier; Emmanuel Sonnet; Zarrin Alavi; Nathalie Roudaut; Emmanuel Nowak; Angélina Dion; Véronique Kerlan
Journal:  Diabetes Metab Res Rev       Date:  2018-06-01       Impact factor: 4.876

9.  [Real-world evidence vs EBM: what does real-world data add?]

Authors:  Matteo Franchi; Giovanni Corrao
Journal:  Recenti Prog Med       Date:  2021-01

10.  Optimal prandial timing of bolus insulin in diabetes management: a review.

Authors:  D Slattery; S A Amiel; P Choudhary
Journal:  Diabet Med       Date:  2017-11-06       Impact factor: 4.359

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.